NeoPharm CO., LTD. (KOSDAQ:092730)

NeoPharm CO., LTD. Revenue

NeoPharm CO., LTD. had revenue of 32.20B KRW in the quarter ending September 30, 2025, with 23.12% growth. This brings the company's revenue in the last twelve months to 129.81B, up 15.70% year-over-year. In the year 2024, NeoPharm CO., LTD. had annual revenue of 119.01B with 22.56% growth.

• Revenue (ttm): 129.81B
• Revenue Growth: +15.70%
• P/S Ratio: 2.36
• Revenue / Employee: 729.29M
• Employees: 178
• Market Cap: 306.73B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	119.01B	21.91B	22.56%
Dec 31, 2023	97.10B	12.07B	14.20%
Dec 31, 2022	85.03B	-2.90B	-3.30%
Dec 31, 2021	87.93B	6.31B	7.72%
Dec 31, 2020	81.63B	-1.61B	-1.94%